Global Situation
In 2000, it is estimated that there were 10.4 million new cases of cancer diagnosed worldwide, 6.5 million deaths from cancer, and over 25 million persons alive with cancer. Taking account of the growth and ageing of the world's population, and factoring in an annual increase in cancer incidence and mortality of 1%, by 2030 it could be expected that there will be 25.4 million incident cases of cancer, 16.4 million cancer deaths annually, and 75 million persons alive with cancer. The greatest effect of this increase will fall on low-resource and medium-resource countries where, in 2000, almost half of the disease burden was from non-communicable disease. Apart from population growth and ageing, the exportation of cancer risk factors from developed countries, notably tobacco smoking, to add to existing cancer risk factors in developing countries is, and will continue to be, a major determinant of cancer risk and the cancer burden in these countries. Low-resource and medium-resource countries are, arguably, harder hit by cancer than the high-resource countries. Such countries often have a limited health budget and a high background level of communicable disease. Cancer treatment facilities are not universally available and life-extending therapies are often unavailable generally for economic reasons. Cancer and other chronic diseases, which are becoming more common, can cause devastating damage to entire families. A major challenge for many countries is how to find sufficient funds to treat the large numbers of cancers which will be diagnosed in the coming years. Effective prevention will reduce the risk of cancer and effective screening will allow many others to be successfully treated for their disease. Prevention actions can be implemented today to reduce the burden of major cancer killers: e.g. tobacco control against lung cancer and other forms of cancer and vaccination against cancers of the cervix and liver. The Millennium Development Goals have galvanised unprecedented efforts to meet the needs of the world's poorest communities and their successful realisation will be of immense value to many populations worldwide. Cancer Prevention and Control needs to acquire the same focus as provided by the MDGs: the Millennium Development Goals make no explicit mention of cancer, or other chronic disease, but deal with them in goal 6 "Combat HIV/AIDS, malaria and other diseases". There needs to be greater incentive developed for low-resource and medium-resource countries to prioritise cancer and other chronic diseases. Although increasingly many medium-resource countries assign high priority in their national health strategies to chronic diseases, including cancer, the donor community and most bilateral development agencies do not allocate cancer control an adequately high priority. If cancer is Late Abstract not given higher priority through focused global efforts, healthcare systems in low-income and middle-income countries will encounter even further problems as the number of cancer cases increase. More and more people will die prematurely and needlessly from cancer, with devastating social and economic consequences for households, communities, and countries alike. Cancer could become a major impediment to socioeconomic development in low income and economically emerging nations. The timing is now right to address this growing cancer burden 5 . The World Health Organization Resolution on Cancer Prevention and Control (WHA58.22) provides a strong impetus for countries to develop programmes aimed at the reduction of cancer incidence and mortality and determining strategic priorities to achieve progress. Such priorities must be realistic and achievable, and include a focus on low-resource and medium-resource countries and the identification, delivery, and assessment of effective cancer control measures. Depending on resources and competing health priorities, all steps must be taken to avoid those cancers which are avoidable; to treat those cancers which are treatable; to cure those cancers which are curable; and to provide palliation to those patients who need palliative care.
